UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 3.

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, J-J; Nathan, P; Dummer, R; Forsea, A-M; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; et al (2017). More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. European Journal of Cancer, 75:313-322.

Chapman, P B; Hauschild, A; Robert, C; Haanen, J B; Ascierto, P; Larkin, J; Dummer, R; Garbe, C; Testori, A; Maio, M; Hogg, D; Lorigan, P; Lebbe, C; Jouary, T; Schadendorf, D; Ribas, A; O'Day, S J; Sosman, J A; Kirkwood, J M; Eggermont, A M M; Dreno, B; Nolop, K; Li, J; Nelson, B; Hou, J; Lee, R J; Flaherty, K T; McArthur, A G (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New England Journal of Medicine, 364(26):2507-2516.

Matin, R N; Mesher, D; Proby, C M; McGregor, J M; Bouwes Bavinck, J N; del Marmol, V; Euvrard, S; Ferrandiz, C; Geusau, A; Hackethal, M; Ho, W L; Hofbauer, G F L; Imko-Walczuk, B; Kanitakis, J; Lally, A; Lear, J T; Lebbe, C; Murphy, G M; Piaserico, S; Seckin, D; Stockfleth, E; Ulrich, C; Wojnarowska, F T; Lin, H Y; Balch, C; Harwood, C A (2008). Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. American Journal of Transplantation, 8(9):1891-1900.

This list was generated on Fri Jul 21 07:34:37 2017 CEST.